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ABSTRACTS 
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Secondary sympathetic activation with wasodilating 
agents can mask these drugs' intrinsic negative 
inotropic effect. Accordingly, we developed a new method 
to assess LW contractility independent of load and 
reflex sympathetic changes. 14 non-ischemic hypertensive 
pts (mean BP=124114 Hg) were studied using echo-Doppler 
while on placebo and 1 wk after therapy with nifedipine 
(Nif). LW end systolic stress (ESS) - rate corrected 
velocity of shortening (Wcfc) 
over a range of loads induced b 
was assessed using Wcfc at a co n LW afterload. At 
each study, data were acquired ore and during IV 
esmolol (Esm) to determine the presence of significant 
reflex cardiac sympathetic responses. The adequacy of 6.. 
sessed with isuprel. 
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In 12/14 pts, nlfedipine au 
contractility. Ablation of 
with esmolol unmasked nifedipine's negative fnotropic 
effect in 9/14 pts. Thus, this noninvasive technique can 
be used to isolate intrinisic contractility changes in 
drugs with combined wasodilator and inotropic action. 
IS ATROPHY A FORM OF CARDIAC ADAPTATION? A STUDY 
PATIENTS WfIH CHRONIC SPINAL CORD NURY 
OF 
Susan B Eysmann, Jeanne If Wei. l¶RY 
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LV mass index (LVMI) was significanlly lower in SC1 than in N (78+-10 
vs 9%7 gh2, j?=.CKll). LV e&d&t& and end-systolic volumes and h were the 
same in both groups, although CO (4.3+-l vs 5.1~..7 Umin), saoke volume (69+- 
13 vs 79+-12 ml), and LA size (3.2+-5 vs 3.7+-.4 cm) were reduced in SC1 
@<.OS). In spile of reductions in LVMI, LV chamber architecture. as described by 
rclaUve wall thiclore-ss .Wi3S 
normal. Resting supin er in 
SC1 (103+-17 vs 127+ end- 
systolic circumferemial wall stress was reduced (143=+44 vs 177+-34 kdkm2, 
pc.03). Ejection fraction and LV fdling pattern were similar in bolh groups. SC1 
had shoner aortic ejection times (.29+-M vs .38+.Q9 sec. p.03) and longer 
accekation tinrz to ejecti .07 vs 28t.06, p=.Ol) suggestive of 
mild systolic dysfunction. w of reducedLVM1 inSCIina 
stepwise regn&on model viky. lower systolic BP and advanced 
findings suggest similar 
INFLUENCE OF INOTROPIC AGENTS ON LEFT VENTRICliLAR 
CONTRACTILITY AND MYOCARDIAL ENERGETICS IN PATIENTS 
WlTH DILATED CARDIOMYOPATHY 
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Matsunami 
Nagoya University, Nagoya, Japan 
Left. ventricular contractile state and energy conversion 
efficiency were investigated in 11 patients with dilated 
cardiomyopathy, using left ventricular pressure-volume 
relation before and after administration of dobutamlne(DOB) 
and oral phosphodiesterase inhibitor(MS-857). Pressure- 
volume area(PVA), external work(EW), end-systolic 
elastance(Ees), and effective arterial elast.ance(Ea) were 
measured using continuous pressure-volume diagram 
obtained by a conductance catheter. Myocardlal oxygen 
consumpiion iMV&) was measured using coronary sinus flow 
and oxygen difference from a coronary sinus catheter. 
After administration of MS-857 and DOB, slgnlflcant 
increase in Ees(l.OO to 1.35 mmHg/ml after MS-857, and 1.12 
Lo 1.54 after DOB), decrease in Ea(2.75 to 2.35 mmHg/ml after 
MS-857, and 2.45 to 2.15 after DOB), and decrease In Ea/Ees 
(3.15 to 2.07 after MS-857, and 2.84 to 1.54 after DOB) toward 
a so called optimal ventriculoarterial coupling were observed. 
As a result, EW/PVA efficiency increased from 33 to 40% after 
MS-857 and from 34 to 112% after DOB. 
Both energy conversion efficiency PVA/MVO, and Ek/MVO;. 
had a inverse relation to Ees(r=-0.81 and r=-0.78, p<O.O5), 
while EW/PVA increased with Ees(r=Q.66,p<0.05). In 
conclusion, inotropic agents increase contractility and 
external work efficiency, but have a possibility of oxygen 
wasting effect in patients with dilated cardiomyopathy. 
Alan S. Wolllister, Ted 
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order to measure the ynamic and renal 
cts of atria1 natriure actor (ANF), we 
infused ANF at 0.01, 0.03 and 0.1 ug/kg/min for 
45 min at each dose in 5 class IV heart failure 
(CHF) and 5 normal (Nl) subjects during 
continuous hemodynamic monitoring. Plasma ANF 
levels increased similarly in both groups (Nl: 
2425 to 1105+147, CHF: 117222 to 1470~158 pg/ml 
PcO.001 for both) and were associated with 
significant fa 
CHF: -6.5k1.6 
-5.2 +0.3, CHF 
capillary wedge pressures (PCWP) (Nl: -5.QO.6, 
CHF: -12.722.1) (all p<O.OOl) at the highest 
dose. The final filling pressures in CHF (RA: 
5.7+ 2.8, PCWP 11.123.5 mmHg) were similar to 
the-initial pressures in Nl (RA: 6.022.1, PCWP 
9.823.6 mmHg, P=NS for both). Urine flow rate 
rose significantly in both groups (Nl: 6.6i1.2 
to 25.796.3 ml/min, CHF: 2.2+0.6 to 7.Q3.4, 
~~0.05 for both). Urine sodTurn loss rose in a 
similar significant fashion (nl: 211 
1367+179 and CHF: 17&4 to 232+73 uEg/ 
for both). 
We conclude that the hemo 
and natriuretic effects of F are ravorable 
and can normalize the baseline abnormalities 
that exist in end-stage heart failure. 
